FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients

被引:9
|
作者
Incerti, E. [1 ]
Broggi, S. [2 ]
Fodor, A. [3 ]
Cuzzocrea, M. [4 ]
Gajate, A. M. Samanes [1 ]
Mapelli, P. [1 ,5 ]
Fiorino, C. [2 ]
Dell'Oca, I. [3 ]
Pasetti, M. [3 ]
Cattaneo, M. [2 ]
Calandrino, R. [2 ]
Gianolli, L. [1 ]
Di Muzio, N. [3 ]
Picchio, Maria [1 ,5 ]
机构
[1] IRCCS San Raffaele Sci Inst, Unit Nucl Med, Via Olgettina 60, I-20132 Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Unit Med Phys, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Unit Radiotherapy, Milan, Italy
[4] Univ Milano Bicocca, Milan, Italy
[5] Vitasalute San Raffaele Univ, Milan, Italy
关键词
Malignant pleural mesothelioma; FDG PET; CT; Helical tomotherapy; Survival; MTV; TLG; POSITRON-EMISSION-TOMOGRAPHY; RADIATION-THERAPY; PREOPERATIVE EVALUATION; PHASE-III; RADIOTHERAPY; CHEMOTHERAPY; ORGANIZATION; MANAGEMENT; 18F-FDG-PET/CT; PREDICTION;
D O I
10.1007/s00259-018-4056-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeThe value of FDG PET-derived parameters in predicting overall survival (OS), local relapse-free survival (LRFS) and distant relapse-free survival (DRFS) in treated patients with malignant pleural mesothelioma (MPM) was evaluated.MethodsThis retrospective evaluation included 55 MPM patients treated between March 2006 and February 2015 with FDG PET/CT-guided salvage helical tomotherapy (HTT) after previous surgery plus chemotherapy. Univariate Cox regression analysis was performed to assess the impact of the following FDG PET-derived parameters: biological target volume (BTV), mean and maximum standardized uptake values (SUVmean/max), metabolic tumour volume (MTV) and total lesion glycolysis (TLG), measured using different uptake thresholds (40%, 50% and 60%). Logistic regression was then performed to identify the best FDG PET-derived parameters for selecting patients with poorer survival.ResultsThe median OS was 9.1months (range 0.0 - 69.6months) after the end of HTT; 54/55 patients were dead at the last follow-up. BTV and TLG40, TLG50 and TLG60 were the most significant predictors of OS (p<0.005). The median OS was 4.8months in patients with MTV60 >5cm(3) and TLG40 >334.4, compared with 13.8months and 16.1months in patients with smaller values, respectively. The median LRFS and DRFS were 6.2months (range 1.2 - 39.4months) and 6.5months (0.0 - 66.4months), respectively. TLG40, TLG50 and TLG60 were significantly correlated with LRFS (p<0.015). Median DRFS was 6.4months in patients with MTV40 >39.6cm(3) and 6.2months in patients with TLG40 >334.4, compared with 17months and 18.8months in patients with smaller values. BTV, TLG40 and MTV40 were also found to be good predictors in patients with poor OS/LRFS/DRFS (median survival times less than the median values).ConclusionFDG PET-derived parameters effectively discriminated patients with a poor prognosis and may be helpful in the selection of MPM patients for salvage HTT.
引用
收藏
页码:2071 / 2078
页数:8
相关论文
共 50 条
  • [1] FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients
    E. Incerti
    S. Broggi
    A. Fodor
    M. Cuzzocrea
    A. M. Samanes Gajate
    P. Mapelli
    C. Fiorino
    I. Dell’Oca
    M. Pasetti
    M. Cattaneo
    R. Calandrino
    L. Gianolli
    N. Di Muzio
    Maria Picchio
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2071 - 2078
  • [2] FDG PET-derived parameters as prognostic tool in post-treatment progressive malignant pleural mesothelioma patients
    Incerti, E.
    Mapelli, P.
    Broggi, S.
    Fodor, A.
    Cuzzocrea, M.
    Gajate, A. M. Samanes
    Fiorino, C.
    Dell'Oca, I.
    Gianolli, L.
    Di Muzio, N.
    Picchio, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S672 - S672
  • [3] Predictive role of FDG PET-derived parameters on outcome after salvage radiotherapy in progressive malignant pleural mesothelioma
    Incerti, Elena
    Mapelli, Paola
    Broggi, Sara
    Fodor, Andrei
    Cuzzocrea, Marco
    Gajate, Ana Maria Samanes
    Fiorino, Claudio
    Cattaneo, Mauro
    Dell'Oca, Italo
    Pasetti, Marcella
    Calandrino, Riccardo
    Di Muzio, Nadia
    Gianolli, Luigi
    Picchio, Maria
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [4] Prognostic value of FDG PET imaging in malignant pleural mesothelioma
    Bénard, F
    Sterman, D
    Smith, RJ
    Kaiser, LR
    Albelda, SM
    Alavi, A
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (08) : 1241 - 1245
  • [5] Prognostic value of FDG PET imaging in malignant pleural mesothelioma
    Ng, DCE
    Hain, SF
    O'Doherty, MJ
    Dussek, J
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (08) : 1443 - 1444
  • [6] Prognostic value of 18F-FDG-PET for patients with malignant pleural mesothelioma treated with double immunotherapy
    Thunold, S. M. H.
    Hernes, E.
    Farooqi, S. J.
    Mikalsen, L. T. G.
    Ojlert, A. K.
    Helland, A.
    Malinen, E.
    Haakensen, V. D.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1135 - S1136
  • [7] Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma
    Lee, S. T.
    Ghanem, M.
    Herbertson, R. A.
    Berlangieri, S. U.
    Byrne, A. J.
    Tabone, K.
    Mitchell, P.
    Knight, S. R.
    Feigen, M.
    Scott, A. M.
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (06) : 473 - 479
  • [8] Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma
    S. T. Lee
    M. Ghanem
    R. A. Herbertson
    S. U. Berlangieri
    A. J. Byrne
    K. Tabone
    P. Mitchell
    S. R. Knight
    M. Feigen
    A. M. Scott
    [J]. Molecular Imaging and Biology, 2009, 11 : 473 - 479
  • [9] The prognostic value of FDG-PET imaging in malignant pleural mesothelioma.
    Bénard, F
    Alavi, A
    Sterman, D
    Shnier, D
    Smith, RJ
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 81P - 81P
  • [10] Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer
    Mapelli, P.
    Bergamini, A.
    Fallanca, F.
    Rancoita, P. M., V
    Cioffi, R.
    Incerti, E.
    Rabaiotti, E.
    Petrone, M.
    Mangili, G.
    Candiani, M.
    Gianolli, L.
    Picchio, M.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (01): : 3 - 9